PlainRecalls
FDA Drug Moderate Class II Terminated

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07.

Reported: March 9, 2022 Initiated: February 15, 2022 #D-0632-2022

Product Description

Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07.

Reason for Recall

cGMP deviations

Details

Recalling Firm
Macleods Pharma Usa Inc
Units Affected
3,672 bottles
Distribution
USA Nationwide
Location
Plainsboro, NJ

Frequently Asked Questions

What product was recalled?
Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plainsboro, NJ 08536, Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-192-07.. Recalled by Macleods Pharma Usa Inc. Units affected: 3,672 bottles.
Why was this product recalled?
cGMP deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on March 9, 2022. Severity: Moderate. Recall number: D-0632-2022.